Income Statement (TTM)
FibroGen, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 119 | 176 | 190 | 172 | 284 | 235 | 258 | 263 | 123 | 141 | 116 | 131 | 155 | 47 | 36 | -7 | -1 | 30 | 7 | 7 |
| Change (%) | 47.80 | 7.96 | -9.73 | 65.15 | -17.08 | 9.52 | 2.11 | -53.29 | 14.50 | -17.53 | 12.50 | 18.69 | -69.80 | -23.07 | -120.31 | -84.76 | -2,756.59 | -76.38 | 5.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 239 | 261 | 284 | 345 | 364 | 449 | 404 | 356 | 357 | 300 | 285 | 308 | 294 | 295 | 275 | 206 | 168 | 111 | 63 | 36 |
| Change (%) | 9.17 | 8.96 | 21.53 | 5.35 | 23.53 | -9.98 | -11.84 | 0.10 | -15.94 | -5.09 | 8.22 | -4.56 | 0.36 | -6.83 | -24.98 | -18.64 | -33.70 | -43.51 | -42.24 | |
| % of Revenue | 200.13 | 147.82 | 149.20 | 200.88 | 128.14 | 190.89 | 156.91 | 135.47 | 290.33 | 213.13 | 245.26 | 235.93 | 189.72 | 630.45 | 763.56 | -2,819.78 | -15,049.87 | 375.59 | 898.34 | 494.13 |
| Gross Operating Profit | -119 | -84 | -94 | -173 | -80 | -214 | -147 | -93 | -234 | -159 | -169 | -177 | -139 | -248 | -239 | -214 | -169 | -82 | -56 | -29 |
| Change (%) | -29.41 | 11.06 | 85.08 | -53.93 | 167.85 | -31.43 | -36.35 | 150.60 | -31.94 | 5.90 | 5.28 | -21.66 | 78.55 | -3.77 | -10.62 | -20.90 | -51.67 | -31.58 | -48.16 | |
| % of Revenue | -100.13 | -47.82 | -49.20 | -100.88 | -28.14 | -90.89 | -56.91 | -35.47 | -190.33 | -113.13 | -145.26 | -135.93 | -89.72 | -530.45 | -663.56 | 2,919.78 | 15,149.87 | -275.59 | -798.34 | -394.13 |
| SG&A | 115 | 108 | 88 | 57 | 131 | 135 | 134 | 132 | 136 | 142 | 146 | 146 | 142 | 86 | 69 | 53 | 45 | 49 | 41 | 33 |
| Change (%) | -6.36 | -18.57 | -35.37 | 132.21 | 2.44 | -0.16 | -1.71 | 3.07 | 4.13 | 2.62 | 0.63 | -2.96 | -39.15 | -20.31 | -23.61 | -15.23 | 10.53 | -17.45 | -19.28 | |
| % of Revenue | 96.29 | 61.00 | 46.01 | 32.94 | 46.32 | 57.22 | 52.16 | 50.21 | 110.80 | 100.77 | 125.38 | 112.15 | 91.70 | 184.78 | 191.42 | -719.85 | -4,002.69 | 166.54 | 582.08 | 447.48 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 354 | 368 | 372 | 402 | 495 | 584 | 539 | 489 | 493 | 442 | 430 | 455 | 436 | 382 | 344 | 259 | 212 | 161 | 104 | 69 |
| Change (%) | 4.13 | 0.92 | 8.12 | 23.22 | 17.93 | -7.71 | -9.31 | 0.90 | -10.40 | -2.62 | 5.66 | -4.04 | -12.52 | -9.88 | -24.71 | -17.94 | -24.41 | -35.50 | -33.21 | |
| % of Revenue | 296.42 | 208.83 | 195.21 | 233.82 | 174.46 | 248.12 | 209.08 | 185.69 | 401.13 | 313.90 | 370.64 | 348.08 | 281.42 | 815.23 | 954.97 | -3,539.64 | -19,052.56 | 542.13 | 1,480.42 | 941.61 |
| Operating Income | -234 | -192 | -181 | -230 | -211 | -349 | -281 | -225 | -370 | -301 | -314 | -324 | -281 | -335 | -308 | -266 | -214 | -131 | -97 | -62 |
| Change (%) | -18.11 | -5.55 | 26.87 | -8.11 | 64.96 | -19.35 | -19.78 | 64.14 | -18.67 | 4.35 | 3.13 | -13.21 | 19.06 | -8.04 | -13.53 | -19.78 | -38.67 | -26.26 | -35.98 | |
| % of Revenue | -196.42 | -108.83 | -95.21 | -133.82 | -74.46 | -148.12 | -109.08 | -85.69 | -301.13 | -213.90 | -270.64 | -248.08 | -181.42 | -715.23 | -854.97 | 3,639.64 | 19,152.56 | -442.13 | -1,380.42 | -841.61 |
| Interest Expense | -3 | -2 | -2 | -2 | -2 | -1 | -1 | -0 | -0 | -1 | -4 | -7 | -12 | -8 | -8 | -7 | -7 | -8 | -8 | -9 |
| Change (%) | -5.10 | -5.50 | -13.04 | -23.86 | -28.48 | -37.58 | -31.89 | -5.69 | 234.11 | 157.99 | 78.82 | 74.36 | -30.11 | -3.46 | -15.37 | -0.44 | 25.24 | 2.00 | 1.66 | |
| % of Revenue | -2.12 | -1.36 | -1.19 | -1.15 | -0.53 | -0.46 | -0.26 | -0.17 | -0.35 | -1.02 | -3.20 | -5.09 | -7.47 | -17.30 | -21.70 | 90.43 | 590.58 | -27.84 | -120.24 | -116.42 |
| Net Income | -229 | -189 | -183 | -231 | -215 | -290 | -281 | -220 | -362 | -294 | -307 | -322 | -294 | -284 | -240 | -168 | -122 | -48 | -10 | -2 |
| Change (%) | -17.26 | -3.48 | 26.64 | -7.26 | 35.16 | -2.95 | -21.80 | 64.26 | -18.78 | 4.60 | 4.90 | -8.70 | -3.38 | -15.40 | -30.00 | -27.64 | -60.93 | -78.97 | -79.35 | |
| % of Revenue | -191.78 | -107.36 | -95.98 | -134.66 | -75.62 | -123.25 | -109.22 | -83.64 | -294.16 | -208.66 | -264.63 | -246.75 | -189.81 | -607.29 | -667.83 | 2,301.39 | 10,923.14 | -160.63 | -143.04 | -28.12 |
Source: Capital IQ
